Synthomer plc (LON:SYNT - Get Free Report) insider Janet E. Ashdown bought 19,920 shares of the firm's stock in a transaction that occurred on Thursday, July 3rd. The stock was bought at an average price of GBX 99 ($1.35) per share, for a total transaction of £19,720.80 ($26,841.98).
Synthomer Stock Down 0.2%
Shares of SYNT stock traded down GBX 0.20 ($0.00) on Monday, reaching GBX 93.70 ($1.28). 335,765 shares of the company's stock traded hands, compared to its average volume of 723,753. Synthomer plc has a 12-month low of GBX 78.20 ($1.06) and a 12-month high of GBX 293.50 ($3.99). The company has a debt-to-equity ratio of 78.27, a quick ratio of 0.97 and a current ratio of 1.90. The company has a market capitalization of £153.65 million, a P/E ratio of -1.88, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79. The business's 50 day moving average price is GBX 103.87 and its two-hundred day moving average price is GBX 118.58.
Analyst Upgrades and Downgrades
Separately, Berenberg Bank downgraded Synthomer to a "hold" rating and lowered their price target for the company from GBX 230 ($3.13) to GBX 150 ($2.04) in a report on Wednesday, March 12th.
Get Our Latest Report on SYNT
Synthomer Company Profile
(
Get Free Report)
Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide.
Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.
Featured Articles
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.